Allworth Financial LP Sage Therapeutics, Inc. Transaction History
Allworth Financial LP
- $16.1 Billion
- Q3 2024
A detailed history of Allworth Financial LP transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 315 shares of SAGE stock, worth $1,990. This represents 0.0% of its overall portfolio holdings.
Number of Shares
315
Previous 132
138.64%
Holding current value
$1,990
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding SAGE
# of Institutions
215Shares Held
47.8MCall Options Held
854KPut Options Held
195K-
Vanguard Group Inc Valley Forge, PA6.42MShares$40.6 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.48MShares$34.6 Million0.99% of portfolio
-
Black Rock Inc. New York, NY5.22MShares$33 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.46MShares$28.2 Million0.81% of portfolio
-
State Street Corp Boston, MA2.47MShares$15.6 Million0.0% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $376M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...